Zemazis Sachets (for Eczema)

Product Highlights & Key Claims

• Used in highly developed countries (in EU) for more than 70 years, launched for the first time in India by Prazis Healthcare Private Limited.
• Recent advancements in medical research confirm that eczema is not just a skin disease. Eczema is caused by overgrowth of harmful bacteria Staphylococcus aureus, and simultaneous loss of other, potentially beneficial bacteria on the skin. This along with disturbances in the gut-bran-skin axis causes eczema.
• Current therapy approaches offer only symptomatic relief, they cannot completely cure eczema because they do not address the root cause (disturbances in the gut-bran-skin axis).
• Zemazis corrects the gut-brain-skin axis, thereby treats the root cause of eczema. Zemazis is highly effective and a valuable agent in the treatment of eczema.
• Safe, no side effects unlike conventional therapies.
• S. cerecisiae is US FDA GRAS certified.
• After completing the course (1 month), Zemazis effectively relieves the symptoms.

Please read the enclosed patient information leaflet (contains directions for use, precautions etc.) before using the product.